Keros Therapeutics (KROS) traded down -0.62 % during a 24 hours period ending at 03:29 AM Central Europe on Tuesday 27th. One Keros Therapeutics stock can currently be bought for about USD 11.33 on popular exchanges. Current supply of Keros Therapeutics stocks is 19.8 mn. Keros Therapeutics has a current market capitalization of USD 223.7 mn and approximately USD 1.4 mn worth of Keros Therapeutics was traded on exchanges in the last 24 hours. Since last month end, Keros Therapeutics has traded -2.34 % down. Simple moving average of last 200 days is at USD 12.26. The highest price of past 52 weeks was recorded at USD 22.55 on 12/08/2025. 52 weeks low was at USD 9.69 on 08/04/2026.
Here is how related stocks have performed in the past 24 hours:
Catalyst Acquisition (CATLU) traded down -0.1 % and now trades at USD 9.97. Current market capitalisation for Catalyst Acquisition is USD 266.7 mn.
Bcb (BCBP) traded up 0.47 % and now trades at USD 8.57. Current market capitalisation for Bcb is USD 265.4 mn.
Karman Line Acquisition (XTERU) traded flat 0 % and now trades at USD 9.88. Current market capitalisation for Karman Line Acquisition is USD 267.2 mn.
Century Therapeutics (IPSC) traded down -7.59 % and now trades at USD 1.42. Century Therapeutics has a market capitalisation of USD 264.4 mn.
Horizon Finance C (HRZN) traded down -1 % and now trades at USD 3.96. Horizon Finance C has a market capitalisation of USD 265.5 mn. Horizon Finance C has a current price to earnings ratio of 39.03.
About Keros Therapeutics
Keros Therapeutics, Inc. is a biotechnology company that operates in the health care sector with its main focus on discovering and developing novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company has its base in Lexington, United States, and serves customers worldwide.
